entertainment -WSS

entertainment

author：hotspot 2025-09-14 10:30:51 - browse：5

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

LONDON — A drug in development as a weight loss treatment succeeded in a Phase 2 study in a serious liver condition, its developers said Monday, as the competition in the broader obesity medicine field pushes ahead.

The drug, survodutide, is being developed by the privately held German firm Boehringer Ingelheim and the Danish biotech Zealand Pharma. Zealand’s share price has doubled over the past year over the potential of the drug, and on Monday morning, shares jumped another 25%.

In the study, 83% of patients with a condition called MASH and who were treated with survodutide saw significant improvements in their disease compared to 18% of those who received placebo. The study met its primary endpoint of improvements in MASH after 48 weeks without the worsening of fibrosis, a scarring of the liver, the companies said. Secondary endpoints were also met, including an improvement in fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： AI used to predict Covid

entertainment

WSS

Heat waves linked to early deliveries, preterm births in new study

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Amazon expands telehealth clinic nationwide

The high personal cost of affirmative action for Black doctors

Latest bird flu infection made farmworker sicker than earlier cases

First Opinion Podcast: What happens when kids become caregivers?

knowledge

entertainment

explore

Anesthesiologist group: stop taking Ozempic before surgery

Scientists inch closer to single

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

AI used to predict Covid

In Memoriam: Notable people who died in 2023

Scientists successfully use ultrasound imaging to map brain activity

Moonlake's readout produced a cash windfall. Risks remain

Mitch McConnell episode has important public health takeaway

entertainment

iTeos Therapeutics debuts first data on TIGIT

Vertex non

Infectious disease expert Jeanne Marrazzo assumes Fauci role

National panel will explore requiring free Covid tests

Adults seen as increasingly susceptible to measles

Adam's Biotech Scorecard: Do Sarepta's exon

focus

entertainment

focus

leisure time